Share page on FacebookShare page on TwitterShare page on LinkedIn
ICON plc
  • Services

    Services

    Our services span the entire lifecycle of product development and commercialisation, and can be adapted to suit small local trials or large global programs.

    Read More
    Services
    Adaptive TrialsClinical Research ServicesConsultingEarly PhaseFunctional Services ProvisionLaboratoriesLanguage ServicesMedical ImagingReal World IntelligenceSite & Patient Solutions Value Access Outcomes
    Clinical trials during COVID-19.
    COVID-19 clinical operations

    Clinical trials during COVID-19.

    Bringing the clinical trial to the patient with innovation and in-home solutions.
    Decentralised & hybrid clinical solutions

    Bringing the clinical trial to the patient with innovation and in-home solutions.

  • Sectors

    Sectors

    ICON provides its full range of clinical, consulting and commercial services across several industry sectors.

    Read More
    Sectors
    BiosimilarsBiotechGovernment & Public Health SolutionsMedical DevicePharmaceuticals
    A roadmap to meet 2022 deadlines, while navigating pandemic disruptions.
    The IVDR journey

    A roadmap to meet 2022 deadlines, while navigating pandemic disruptions.

    Serving governments, multinational public health organisations, and global NGOs.
    Government and Public Health Solutions

    Serving governments, multinational public health organisations, and global NGOs.

  • Therapeutics

    Therapeutics

    We have extensive experience in a broad range of therapeutic areas. Managing studies in all major geographies, we have established solid working relationships with the world’s leading investigators.

    Read More
    Therapeutics
    CardiovascularCell and Gene TherapiesCentral Nervous SystemEndocrine & Metabolic DisordersInfectious DiseasesInternal Medicine & ImmunologyMedical DeviceOncologyRare & Orphan DiseasesTransplant ImmunologyWomen's Health
    ICON has recently led the development of 17 vaccines resulting in FDA/EMA approvals. We are currently working on a number of COVID-19 vaccine trials.
    Vaccines

    ICON has recently led the development of 17 vaccines resulting in FDA/EMA approvals. We are currently working on a number of COVID-19 vaccine trials.

    ICON's therapeutic experts contribute regularly to industry publications and the creation of thought leadership content. Read more.
    Therapeutics insights

    ICON's therapeutic experts contribute regularly to industry publications and the creation of thought leadership content. Read more.

  • Innovation

    Innovation

    We develop integrated technologies to significantly enhance the efficiency and productivity of clients’ drug and device development programs.

    Read More
    Innovation
    FIRECRESTSafety Reporting SolutionOne SearchEvidence PlatformFLEX ADVANTAGE Medical Imaging TechnologyNONMEM ICONIKPDx-POPPubsHubSIMS
    With travel restrictions due to COVID-19, FIRECREST helps deliver and manage remote training for investigators.
    FIRECREST

    With travel restrictions due to COVID-19, FIRECREST helps deliver and manage remote training for investigators.

    Connecting patients with the right trial in the right location.
    Patient Engagement Platform

    Connecting patients with the right trial in the right location.

  • Insights

    Insights

    BioPharma companies and Medical Devices manufacturers face growing operational, regulatory and economic challenges. ICON provides analysis and key insights on these challenges, with practical advice and recommendations.

    Read More
    Insights
    Digital Disruption Patient CentricityRegulatory IntelligenceTherapeutics insightsTransforming TrialsValue Based HealthcareBlogVideosWebinar Channel
    Aggregated news on COVID-19 clinical trials.
    Coronavirus Observatory

    Aggregated news on COVID-19 clinical trials.

    Patient focused research for better outcomes.
    Decentralised & hybrid clinical trials

    Patient focused research for better outcomes.

  • News & Events

    News & Events

    ICON regularly contributes thought leadership to industry media publications and conferences, and has been recognised as one of the world’s leading Contract Research Organisations through a number of high-profile industry awards.

    Read More
    News & Events
    Press ReleasesIn the NewsMediakitAwardsEventsWebinarsSocial Media
    Creating a world leader in healthcare intelligence and clinical research.
    ICON to acquire PRA Health Sciences

    Creating a world leader in healthcare intelligence and clinical research.

    8 April, 2021
    Webinar: Transforming CNS drug development with wet lab and imaging biomarker solutions

    8 April, 2021

  • About ICON

    About ICON

    Our mission is to help clients accelerate the development of drugs and devices that save lives and improve quality of life.

    Read More
    About ICON
    Company HistoryICON in Asia PacificICON in Latin AmericaLeadershipQuality
    ICON is committed to making a positive impact on our people, environment and our community.
    Environmental, Social & Governance

    ICON is committed to making a positive impact on our people, environment and our community.

    Partners making a difference.
    ICON and You

    Partners making a difference.

  • Careers
  • Investors
  • Investigators
  • Patients
  • Contact
  • EN | 日本語
  1. Home
  2. News & Events
  3. Press Releases

Press Releases

  • 24 February 2021

    ICON Reports Fourth Quarter and Full Year 2020 Results

    Record net business wins in the quarter of $1,080 million; a book to bill of 1.42. Full year net business wins of $3.8 billion; a net book to bill of 1.38.

  • 24 February 2021

    ICON to acquire PRA Health Sciences

    Creating a world leader in Healthcare Intelligence and Clinical Research.

  • 8 February 2021

    ICON launches FIRECREST Safety Letters and Site Question Management

    ICON launches FIRECREST Safety Letters and Site Question Management supporting regulatory compliance and increasing site support.

  • 7 January 2021

    ICON plc to present at the 39th Annual JP Morgan Healthcare Conference

    Tuesday, January 12, 2021 at 07.30am ET

  • 4 January 2021

    ICON supports Pfizer and BioNTech on the investigational COVID-19 vaccine trial

    ICON provided both decentralised and on-site clinical trial services to the Pfizer BioNTech COVID-19 vaccine programme.

  • 11 November 2020

    ICON Releases First Environmental, Social and Governance Report

    ICON announces the release of its first Environmental, Social and Governance (ESG) Report.

  • 30 October 2020

    ICON plc to present at the 29th Annual Credit Suisse Virtual Healthcare Conference and Evercore ISI HealthCONx Conference

    ICON plc to present at the 29th Annual Credit Suisse Virtual Healthcare Conference and Evercore ISI HealthCONx Conference

  • 21 October 2020

    ICON Reports Third Quarter 2020 Results

    Quarter 3 reported revenue of $701.7 million representing a year on year decrease of 1.2% and 13.1% increase on Quarter 2 2020.

  • 19 October 2020

    BARDA reselects ICON as preferred partner to help strengthen US emergency preparedness and response

    To help strengthen US emergency preparedness and response. ICON continues as part of BARDA’s exclusive Medical Countermeasures Clinical Studies Network.

  • 7 October 2020

    ICON wins Best CRO at the Vaccine Industry Excellence Awards

    This marks the third time ICON plc has won the award for excellence in vaccine research. The company has been named as a finalist every year since 2011.

  • 1
  • 2
  • 3
  • 4
  • 5
  • ...
  • 11
In this section
In this section
  • Press Releases
  • In the News
  • Mediakit
    • Facts and figures
    • ICON Spokespeople
  • Awards
  • Events
    • Industry Events
    • Webinars
    • Workshops
  • Webinars
  • Social Media
  • ICON to acquire PRA Health Sciences
  • Webinar: Transforming CNS drug development with wet lab and imaging biomarker solutions

Connect with us

  • Contact us
  • Submit proposal request
  • Update Email Preferences
  • Global office locator
  • ICON on social media

What’s happening in ICON

ICON plc
  • Contact
  • About ICON
  • Results & Reports
For Clients
  • Therapeutics
  • Services
  • Insights
  • Innovation
  • Content Preferences
ICON For
  • Patients
  • Volunteers
  • Investigators
  • Jobs & Careers
  • Investors
  • Suppliers
News & Events
  • Press Releases
  • Mediakit
  • Events
  • Social Media Dashboard
  • Coronavirus Observatory
  • LinkedIn
  • Twitter
  • Facebook
  • Youtube
  • © 2021 ICON plc
  • Disclaimer
  • Privacy
  • Site Cookies

Connect with us

Contact us Submit proposal request Update Email Preferences Global office locator ICON on social media